A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
Abroad (travel likely)RecruitingPHASE1
Conditions
Atopic Dermatitis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Arkansas Research Trials, North Little Rock, Arkansas, United States
Contact: Study coordinator (Shawna S Owens)DermDox Centers for Dermatology, Camp Hill, Pennsylvania, United States
Contact: Study coordinator (Elise Magnine)University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Paola Santos)